A print friendly PDF version is available from this Communicable Diseases Intelligence issue's table of contents.
Other non-viral pathogens
Chlamydial infections
Chlamydiae are a unique class of bacteria that are obligate intracellular parasites. Three Chlamydia species are recognised, all of which are human pathogens: C. trachomatis, C. pneumoniae and C. psittaci. The associated diseases, strains, mode of infection and host species are shown in Table 35.Table 35. Characteristics of Chlamydia spp. and strains, modes of transmission and associated human diseases*
Species |
Strains |
Mode of transmission |
Host species |
Associated human diseases |
---|---|---|---|---|
C. trachomatis | LGV (L1, L2, L3) | Sexual | Humans | Lymphogranuloma venereum |
Trachoma (A,B,Ba,C) | Hand to eye, fomites, flies | Humans | Ocular trachoma | |
Trachoma (B,Ba,D-K) | Sexual, hand to eye, neonatal | Humans | Ocular and genital disease, infant pneumonia | |
C. psittaci | Many | Aerosol | Birds, sheep, cats etc | Ornithosis (psittacosis) |
C. pneumoniae | 'TWAR' | Not defined aerosol? | Humans | Bronchitis, pneumonia |
*Adapted from reference 44
Reports of chlamydial infections to LabVISE are shown in Table 36.
Table 36. Laboratory reports to LabVISE of chlamydial infections, 1991 to 2000
Organism |
1991 | 1992 | 1993 | 1994 | 1995 | 1996 | 1997 | 1998 | 1999 | 2000 | Total |
---|---|---|---|---|---|---|---|---|---|---|---|
Chlamydia trachomatis A-K | 59 |
11 |
- |
1 |
1 |
1 |
1 |
- |
1 |
- |
75 |
Chlamydia trachomatis L1-L3 | 18 |
- |
- |
- |
- |
- |
1 |
- |
- |
- |
19 |
Chlamydia trachomatis not typed | 2,615 |
2,563 |
2,835 |
2,178 |
2,579 |
3,803 |
3,980 |
3,158 |
3,295 |
3,154 |
30,160 |
Chlamydia pneumoniae | 2 |
14 |
1 |
- |
2 |
1 |
3 |
- |
2 |
36 |
61 |
Chlamydia psittaci | 139 |
97 |
74 |
114 |
176 |
62 |
51 |
70 |
78 |
102 |
963 |
Chlamydia spp. typing pending | 1 |
10 |
9 |
10 |
6 |
1 |
7 |
- |
1 |
- |
45 |
Chlamydia species not typed | - |
6 |
18 |
62 |
75 |
54 |
28 |
57 |
21 |
8 |
329 |
Total | 2,834 |
2,701 |
2,937 |
2,365 |
2,839 |
3,922 |
4,071 |
3,285 |
3,398 |
3,300 |
31,652 |
Top of page
Chlamydia trachomatis
Notifications of Chlamydial trachomatis infection between 1991 and 2000 to the NNDSS and laboratory reports to LabVISE are shown in Table 37.Table 37. Laboratory reports to LabVISE and notifications to NNDSS of Chlamydia trachomatis infections, 1991 to 2000
Surveillance system |
1991 | 1992 | 1993 | 1994 | 1995 | 1996 | 1997 | 1998 | 1999 | 2000 |
---|---|---|---|---|---|---|---|---|---|---|
LabVISE | 2,692 |
2,574 |
2,835 |
2,179 |
2,580 |
3,804 |
3,982 |
3,158 |
3,296 |
3,154 |
NNDSS | 4,044 |
6,293 |
6,500 |
6,450 |
6,398 |
8,445 |
9,242 |
11,339 |
14,082 |
16,853 |
The NNDSS case definition for chlamydial infections requires the isolation of Chlamydia trachomatis or demonstration of chlamydial antigens in clinical specimens. For most of the study period and from most jurisdictions, notifications to the NNDSS of chlamydial infections were restricted to genital chlamydial infections. New South Wales did not start reporting chlamydial infections to the NNDSS until 1998. LabVISE laboratory reports have fallen from representing two-thirds of the NNDSS reports in 1991 to just 19 per cent in 2000. Whether laboratory reports in LabVISE were from clinical samples only from genital sites or whether they include samples from other infected sites cannot be determined.
The distribution of chlamydial infections by age and sex, reported to LabVISE are shown in Figure 20. The distribution is very similar to that seen in NNDSS notifications, with a female predominance (male to female ratio of 1:1.6) and the largest number of reports (57%) from young adults aged 15-24 years.
Figure 20. Laboratory reports to LabVISE of Chlamydia trachomatis infection, 1991 to 2000, by age and sex
Chlamydia psittaci
Notifications of Chlamydia psittaci infection between 1991 and 2000 to the NNDSS and laboratory reports to LabVISE are shown in Table 38.Table 38. Laboratory reports to LabVISE and notifications to NNDSS of Chlamydia psittaci infections (ornithosis), 1991 to 2000
Surveillance system |
1991 | 1992 | 1993 | 1994 | 1995 | 1996 | 1997 | 1998 | 1999 | 2000 |
---|---|---|---|---|---|---|---|---|---|---|
LabVISE | 139 |
97 |
74 |
114 |
176 |
62 |
51 |
70 |
78 |
102 |
NNDSS | 136 |
98 |
94 |
86 |
186 |
86 |
35 |
64 |
84 |
100 |
Ornithosis has not been a notifiable disease in all Australian jurisdictions during the period 1991 to 2000 and consequently cases reported to the NNDSS do not represent national figures. While no agreed national NNDSS definition for ornithosis was used in this period, probable cases diagnosed based on an acute clinical illness compatible with ornithosis, were included. Laboratory diagnosis is based on increases in specific antibody titres, or more recently, detection of C. psittaci by nucleic acid tests.
For a number of years, LabVISE reported more cases of ornithosis than the NNDSS. LabVISE reports showed a male predominance (male to female ratio 1.7:1) and a peak of reports from adult men aged 50-54 years. Figure 21 shows the age and sex distribution of laboratory reports of ornithosis to LabVISE. This age and sex distribution is similar to that found in notifications of ornithosis to NNDSS.
Figure 21. Laboratory reports to LabVISE of Chlamydia psittaci infections, 1991 to 2000, by age and sex
Top of page
Chlamydia pneumoniae
Chlamydia pneumoniae causes an acute respiratory disease similar to that caused by Mycoplasma. Infection is widespread and antibody prevalence is low in children, around 50 per cent in young adults and continues to be high into old age. Clinical disease is seen in all ages but most frequently in young adults.24Mycoplasma pneumoniae
Mycoplasma pneumoniae is the cause of mycoplasma pneumonia (or primary atypical pneumonia), that presents predominantly as a febrile lower respiratory infection or occasionally as a pharyngitis, bronchitis or pneumonia.24 The disease is worldwide in distribution and may occur in all age groups with occasional epidemics in institutions and military recruits.Laboratory reports to LabVISE of Mycoplasma between 1991 and 2000 are shown in Table 39.
Table 39. Laboratory reports to LabVISE, of Mycoplasma infections, 1991 to 2000
Organism |
1991 | 1992 | 1993 | 1994 | 1995 | 1996 | 1997 | 1998 | 1999 | 2000 | Total |
---|---|---|---|---|---|---|---|---|---|---|---|
Mycoplasma pneumoniae | 381 |
1,580 |
1,760 |
820 |
334 |
1,009 |
1,640 |
1,285 |
1,125 |
686 |
10,620 |
Mycoplasma hominis | 2 |
4 |
- |
2 |
- |
2 |
- |
2 |
5 |
8 |
25 |
Total | 383 |
1,584 |
1,760 |
822 |
334 |
1,011 |
1,640 |
1,287 |
1,130 |
694 |
10,645 |
Mycoplasma pneumoniae infections reported to LabVISE were most commonly reported in female children aged 5-9 years (male to female ratio 0.9:1, Figure 22).
Figure 22. Laboratory reports to LabVISE of Mycoplasma pneumoniae infections, 1991 to 2000, by age and sex
Mycoplasma pneumoniae reports show variation from year to year without a distinct seasonal peak (Figure 23).
Figure 23. Laboratory reports to LabVISE of Mycoplasma pneumoniae infections, 1991 to 2000, by month of report
Mycoplasma hominis is commonly isolated from the genitourinary tract (more commonly from women than men), the neonatal conjunctiva and peripartum blood. The organism is associated with cervicitis, vaginitis, conjunctivitis and peripartum sepsis.45
Top of page
Rickettsia
Coxiella burnetii
The rickettsial pathogen Coxiella burnetii is the cause of an acute febrile disease with a variety of clinical presentations of variable severity and duration (Q fever). The disease is particularly associated with livestock workers. Notifications of Q fever to the NNDSS and laboratory reports of Coxiella burnetii to LabVISE between 1991 and 2000 are shown in Table 40.Table 40. Laboratory reports to LabVISE and notifications to NNDSS of Coxiella burnetii infection (Q fever), 1991 to 2000
Surveillance system |
1991 | 1992 | 1993 | 1994 | 1995 | 1996 | 1997 | 1998 | 1999 | 2000 |
---|---|---|---|---|---|---|---|---|---|---|
LabVISE | 240 |
270 |
552 |
345 |
167 |
208 |
259 |
137 |
221 |
101 |
NNDSS | 595 |
543 |
889 |
664 |
466 |
554 |
580 |
560 |
518 |
573 |
The NNDSS case definition for Q fever46 is based on serology or isolation of the organism from a clinical sample. The trends in laboratory reports to LabVISE are similar to trends in NNDSS data, with a peak in reports in 1993 and lower reports in more recent years as a result of Q fever vaccine initiatives among abattoir workers, who are at high risk of contracting the disease.
An age, sex analysis of Coxiella burnetii infections shows a large male predominance (male:female ratio 5.2:1), similar to that shown in NNDSS data. The largest numbers of laboratory reports to LabVISE were from men aged 25-29 years (Figure 24).
Figure 24. Laboratory reports to LabVISE of Coxiella burnetii infections, 1991 to 2000, by age and sex
Small numbers of laboratory reports of other Rickettsia were sent to LabVISE during the period as shown in Appendix 3.
Top of page
Other pathogens
From 1992 to 1996 and in 1999 and 2000, several hundred reports were made to LabVISE of group A streptococci. While streptococcal group A infections have declined dramatically in Australia, Indigenous Australians in northern Australia continue to suffer endemic infection with corresponding high rates of rheumatic fever,47 acute post-streptococcal glomerulonephritis,48 streptococcal pyoderma49 and resulting chronic renal disease and rheumatic heart disease.A significant number of reports to LabVISE during the period 1991 to 2000 were received for other pathogens under surveillance in the NNDSS (Appendix 2). These include isolations of Yersinia, Brucella, Bordetella, Legionella, Leptospira, Treponema and Echinococcus. Since data on these pathogens was collected sporadically over the period and represent only a small fraction of notified cases reported to NNDSS, no analysis has been attempted here. Similarly for small numbers of reports of Cryptococcus, Entamoeba histolytica and Toxoplasmosis gondii no meaningful comments can be offered.
The reader is referred to NNDSS annual reports published in Communicable Diseases Intelligence for detailed analysis of the epidemiology of these and other pathogens in Australia.
This article was published in Communicable Diseases Intelligence Volume 26, No 3, September 2002
CDI Search
Communicable Diseases Intelligence subscriptions
Sign-up to email updates: Subscribe Now
Communicable Diseases Surveillance
CDI Vol 26, No 3, September 2002
LabVISE, 1991 to 2000
- Contents and Abbreviations
- Abstract and Authors
- Introduction and Methods
- Part A: General results
- Part A: General results cont
- Part B: Analysis of data by pathogen
- Discussion
- Appendices
- References
Communicable Diseases Intelligence